市場調査レポート

商品コード

1566174

神経補綴の市場規模、シェア、成長分析、タイプ別、技術別、用途別、地域別 - 産業予測、2024年～2031年

Neuroprosthetics Market Size, Share, Growth Analysis, By Type, By Technique, By Application, By Region - Industry Forecast 2024-2031

出版日: 2024年10月06日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 763,518円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 893,172円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,022,826円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

神経補綴の世界市場規模は、2022年に103億米ドルと評価され、2023年の115億9,000万米ドルから2031年には297億3,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは12.50％で成長する見通しです。

神経疾患の有病率の上昇と、費用対効果が高く技術的に先進的なインプラントへの需要の高まりが、今後数年間の神経補綴世界市場の成長を促進すると予測されています。さらに、老年人口の増加や聴覚障害、てんかん、アルツハイマー病、重度のうつ病などの疾患の発生率の増加が、市場の拡大にさらに寄与しています。治療改善の必要性が高まるにつれ、神経補綴ソリューションの需要は世界的に高まると予想されます。難聴症例の大幅な増加も市場成長に重要な役割を果たしています。補聴器や人工内耳のような機器は、こうした問題に対処する上で極めて重要です。世界保健機関（WHO）によると、2031年までに世界で約25億人が難聴に悩まされ、約7億人が聴覚リハビリテーションを必要とすると予測されています。このような聴覚障害の負担の増大は、近い将来、神経補綴の需要をさらに押し上げる可能性が高いです。また、大手企業や政府機関による技術の進歩や研究開発への投資の増加も、市場の成長を後押しすると予想されます。例えば、2019年8月、メドエルは、片側難聴と非対称性難聴の患者向けに設計されたSynchrony-2人工内耳システムの承認を米国食品医薬品局から取得し、この分野を前進させる継続的な技術革新を示しています。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Medtronic（US）
Abbott（US）
Cochlear（Australia）
Boston Scientific（US）
Livanova（UK）
Med-El（Austria）
Sonova（Switzerland）
Neuropace（U S）
NDI Medical（Canada）
Nevro（US）
SensArs Neuroprosthetics（Switzerland）
NeuroPace, Inc.（US）
Pixium Vision（France）
NeuroSigma, Inc.（US）
Axonics Modulation Technologies, Inc.（US）
Nervo Corp（US）
Soterix Medical, Inc.（US）
Aleva Neurotherapeutics SA（Switzerland）
Synapse Biomedical, Inc.（US）
Cleveland FES Center（US）

Product Code: SQMIG35A2517

Global Neuroprosthetics Market size was valued at USD 10.3 billion in 2022 and is poised to grow from USD 11.59 billion in 2023 to USD 29.73 billion by 2031, growing at a CAGR of 12.50% during the forecast period (2024-2031).

The rising prevalence of neurological disorders and the growing demand for cost-effective, technologically advanced implants are anticipated to drive the growth of the global neuroprosthetics market in the coming years. Additionally, the increasing geriatric population and the growing incidence of diseases such as auditory disorders, epilepsy, Alzheimer's, and severe depression are further contributing to the market's expansion. As the need for improved treatments grows, the demand for neuroprosthetic solutions is expected to rise globally. The significant increase in hearing loss cases also plays a key role in market growth. Devices like hearing aids and cochlear implants are crucial in addressing these issues. According to the World Health Organization, by 2031, approximately 2.5 billion people worldwide are projected to suffer from hearing loss, with around 700 million expected to require hearing rehabilitation. This growing burden of hearing impairment is likely to further boost demand for neuroprosthetics in the near future. Technological advancements and increased investment in research and development by major companies and government organizations are also expected to fuel market growth. For example, in August 2019, MED-EL received approval from the U.S. Food & Drug Administration for its Synchrony-2 Cochlear Implant System, designed for patients with single-sided deafness and asymmetric hearing loss, illustrating the continuous innovation driving the sector forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neuroprosthetics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Neuroprosthetics Market Segmental Analysis

Global Neuroprosthetics Market is segmented by Type, Technique, Application, and region. Based on Type, the market is segmented into Output Neural Prosthetics, Neural Prosthetic. Based on Technique, the market is segmented into Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, and Transcranial Magnetic Stimulation. Based on Application, the market is segmented into Motor Neuron Disorders, Physiological Disorders, and Cognitive Disorders. Based on end user, the market is segmented into automotive, consumer electronics, healthcare, agriculture, manufacturing, and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Neuroprosthetics Market

The high prevalence of neurological disorders and nerve-related injuries is expected to be a significant driver for the global neuroprosthetics market during the forecast period. For instance, neurological diseases have led to more than 533,000 deaths, with around 213,000 males and 320,000 females affected. Neuroprosthetic devices offer numerous benefits, making them essential in the treatment of such conditions. These devices, such as cochlear implants and auditory brainstem implants (ABI), are particularly beneficial for patients with hearing impairments. As a result, the global demand for neuroprosthetics in diagnosing and treating various neurological disorders is expected to fuel market growth in the coming years. The increasing recognition of the advantages of these devices in improving patient outcomes will likely lead to greater adoption, further propelling the market's expansion.

Restraints in the Global Neuroprosthetics Market

The growing popularity of alternative treatment methods, such as stem cell therapy, is expected to significantly hamper the growth of the neuroprosthetics market during the forecast period. Stem cell therapy provides promising opportunities for treating various neurological conditions, including motor neuron diseases like Parkinson's and Alzheimer's. Its appeal lies in its relatively lower cost compared to neuroprosthetic devices, as well as the simplicity of its treatment regimen, which is attracting more patients toward this alternative option. As a result, the increasing shift toward stem cell treatments is likely to restrain the global expansion of the neuroprosthetics market in the coming years, as patients opt for these cost-effective and less invasive alternatives.

Market Trends of the Global Neuroprosthetics Market

Input neural prosthetics are gaining increasing popularity due to the rising prevalence of hearing loss and technological advancements in the development of various devices. These prosthetics offer significant benefits, such as restoring a sense of sound for individuals who are profoundly deaf or hard of hearing. Their ease of use and relatively low implementation cost make them attractive, creating substantial growth opportunities in the coming years. Research indicates that cochlear implants not only help diagnose hearing loss but are also being recommended as a rehabilitation tool for tinnitus patients suffering from depression. As a result, the neuroprosthetics market is poised for significant growth in the near future, driven by the growing demand for innovative solutions to address hearing loss and other related conditions.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Technology Analysis
Regulatory Analysis
Case Study Analysis

Neuroprosthetics Market by Type

Market Overview
Output Neural Prosthetics
- Motor Prosthetics
- Cognitive Prosthetics
Input Neural Prosthetics
- Cochlear Implants
- Bionic Eye/Retinal Implants

Neuroprosthetics Market by Technique

Market Overview
Spinal Cord Stimulation
Deep Brain Stimulation
Vagus Nerve Stimulation
Sacral Nerve Stimulation
Transcranial Magnetic Stimulation

Neuroprosthetics Market by Application

Market Overview
Motor Neuron Disorders
- Parkinson'S Disease
- Epilepsy
Physiological Disorders
- Auditory Processing Disorders
- Ophthalmic Disorders
- Cardiovascular Disorders
- Urology Disorders
Cognitive Disorders
- Alzheimer'S Disease
- Paralysis

Neuroprosthetics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Medtronic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cochlear (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Livanova (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Med-El (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sonova (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neuropace (U S)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NDI Medical (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nevro (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SensArs Neuroprosthetics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeuroPace, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pixium Vision (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeuroSigma, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Axonics Modulation Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nervo Corp (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Soterix Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aleva Neurotherapeutics SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synapse Biomedical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cleveland FES Center (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

神経補綴の市場規模、シェア、成長分析、タイプ別、技術別、用途別、地域別 - 産業予測、2024年～2031年

Neuroprosthetics Market Size, Share, Growth Analysis, By Type, By Technique, By Application, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

神経補綴市場：タイプ別

神経補綴市場：技術別

神経補綴市場：用途別

神経補綴市場規模：地域別